We’re fortunate to have the opportunity to explore these combinations with the NSGO-CTU and ENGOT as we continue to address the greatest outstanding challenges in oncology.” “Our purpose at the NSGO-CTU and ENGOT is to improve management options in gynaecological cancer indications by conducting and coordinating clinical trial efforts across countries,” added Mansoor Raza Mirza, M. [...] Sotigalimab is currently in Phase 2 clinical development for the treatment of cancers such as esophageal and gastroesophageal junction cancers, melanoma, rectal cancer and sarcoma in various combinations with immunotherapy, chemotherapy, radiation therapy or a cancer vaccine. [...] About NSGO-CTU The Nordic Society of Gynaecological Oncology – Clinical Trial Unit is a non-profit organization aiming to improve the practice of prevention, diagnosis and treatment for gynaecological cancers by supporting research and conducting clinical trials across countries. [...] About ENGOT ENGOT is a platform that guarantees that the European spirit and culture is incorporated into the medical progress in gynaecological oncology, and that all European patients and countries can participate in an active way in clinical research and progress. [...] The ultimate goal is to bring the best treatment to gynaecological cancer patients through the best science and enabling every patient in every European country to access a clinical trial.
Authors
- Pages
- 3
- Published in
- Denmark
